Vargas F, Sabio J M, Luna J D
Facultad de Medicina, Granada, Spain.
Cardiovasc Res. 1994 Sep;28(9):1373-7. doi: 10.1093/cvr/28.9.1373.
The aim was to evaluate the contribution of nitric oxide (NO) and endothelium derived hyperpolarising factor (EDHF) to the endothelium dependent, acetylcholine induced vasodilatation in isolated perfused rat kidney.
The renal response to acetylcholine was compared in phenylephrine preconstricted renal vasculature under basal conditions and after the infusion of N omega-nitro-L-arginine (L-NAME), an inhibitor of NO synthesis, and tetraethylammonium, a non-specific blocker of potassium channels that inhibits acetylcholine induced hyperpolarisation. These inhibitors were given alone and together. In another experiment, the renal response to acetylcholine was compared when the vasculature was preconstricted with phenylephrine or with 40 and 80 mM KCl under basal conditions and after the infusion of L-NAME. All experiments were done in the presence of indomethacin.
Inhibition of NO generation with L-NAME reduced the vasodilator responses to acetylcholine by approximately 50%, and enhanced the response to sodium nitroprusside in the isolated perfused kidney preconstricted with phenylephrine. Infusion of tetraethylammonium also decreased the response to acetylcholine by approximately 50% and increased vasodilatation responses to sodium nitroprusside. The simultaneous administration of both inhibitors (L-NAME and tetraethylammonium) had a summational effect which almost completely suppressed acetylcholine induced vasodilatation. Increasing concentrations of extracellular potassium produced a dose related decrease in acetylcholine induced vasodilatation. These attenuated responses were almost abolished after the infusion of L-NAME.
Our results suggest that the vasodilator response to acetylcholine in isolated perfused rat kidneys is subserved by EDHF and nitric oxide, both endothelium derived mediators participating to a similar extent.
评估一氧化氮(NO)和内皮衍生超极化因子(EDHF)对离体灌注大鼠肾脏中内皮依赖性、乙酰胆碱诱导的血管舒张的作用。
在基础条件下以及在输注一氧化氮合成抑制剂Nω-硝基-L-精氨酸(L-NAME)和四乙铵(一种抑制乙酰胆碱诱导的超极化的钾通道非特异性阻滞剂)后,比较苯肾上腺素预收缩的肾血管系统中肾脏对乙酰胆碱的反应。这些抑制剂单独给药和联合给药。在另一项实验中,比较基础条件下以及输注L-NAME后,当血管系统用苯肾上腺素或40和80 mM氯化钾预收缩时肾脏对乙酰胆碱的反应。所有实验均在吲哚美辛存在的情况下进行。
用L-NAME抑制一氧化氮生成使对乙酰胆碱的血管舒张反应降低约50%,并增强了对硝普钠在苯肾上腺素预收缩的离体灌注肾脏中的反应。输注四乙铵也使对乙酰胆碱的反应降低约50%,并增加了对硝普钠的血管舒张反应。两种抑制剂(L-NAME和四乙铵)同时给药具有累加效应,几乎完全抑制了乙酰胆碱诱导的血管舒张。细胞外钾浓度增加导致乙酰胆碱诱导的血管舒张呈剂量相关的降低。输注L-NAME后,这些减弱的反应几乎完全消失。
我们的结果表明,离体灌注大鼠肾脏中对乙酰胆碱的血管舒张反应由EDHF和一氧化氮介导,这两种内皮衍生介质的参与程度相似。